<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>prednisoLONE</title><link>http://www.unboundmedicine.com/medline/ebm/research/prednisoLONE</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926148/full_citation/VNCOP_B_plus_rituximab_therapy_in_elderly_patients_with_aggressive_B_cell_non_Hodgkin_lymphoma:_A_multicenter_experience_</link><description>Ishii K, Urase F, Nagare Y, et al. <br/><span class="title">VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience. [JOURNAL ARTICLE]</span><br/><span class="source" title="Archives of gerontology and geriatrics">Arch Gerontol Geriatr 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926148/abstract/VNCOP_B_plus_rituximab_therapy_in_elderly_patients_with_aggressive_B_cell_non_Hodgkin_lymphoma:_A_multicenter_experience_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926148/full_citation/VNCOP_B_plus_rituximab_therapy_in_elderly_patients_with_aggressive_B_cell_non_Hodgkin_lymphoma:_A_multicenter_experience_">Full Citation</a></description></item><item><title>Etretinate combined with low-dose prednisolone for an aged patient with adult T-cell leukaemia/lymphoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925487/full_citation/Etretinate_combined_with_low_dose_prednisolone_for_an_aged_patient_with_adult_T_cell_leukaemia/lymphoma_</link><description>Senba-Nakata K, Hatano Y, Ishikawa K, et al. <br/><span class="title">Etretinate combined with low-dose prednisolone for an aged patient with adult T-cell leukaemia/lymphoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical and experimental dermatology">Clin Exp Dermatol 2009 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925487/full_citation/Etretinate_combined_with_low_dose_prednisolone_for_an_aged_patient_with_adult_T_cell_leukaemia/lymphoma_">Full Citation</a></description></item><item><title>Effect of oral prednisolone on visual outcomes and complications after scleral buckling.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19924670/full_citation/Effect_of_oral_prednisolone_on_visual_outcomes_and_complications_after_scleral_buckling_</link><description>Dehghan MH, Ahmadieh H, Soheilian M, et al. <br/><span class="title">Effect of oral prednisolone on visual outcomes and complications after scleral buckling. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of ophthalmology">Eur J Ophthalmol 2009 Nov 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19924670/abstract/Effect_of_oral_prednisolone_on_visual_outcomes_and_complications_after_scleral_buckling_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19924670/full_citation/Effect_of_oral_prednisolone_on_visual_outcomes_and_complications_after_scleral_buckling_">Full Citation</a></description></item><item><title>Transtympanic Steroids for Ménière's Disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19924013/full_citation/Transtympanic_Steroids_for_Ménière's_Disease_</link><description>Herraiz C, Plaza G, Aparicio JM, et al. <br/><span class="title">Transtympanic Steroids for Ménière's Disease. [JOURNAL ARTICLE]</span><br/><span class="source" title="Otology &amp; neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology">Otol Neurotol 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19924013/abstract/Transtympanic_Steroids_for_Ménière's_Disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19924013/full_citation/Transtympanic_Steroids_for_Ménière's_Disease_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19924013/Transtympanic_Steroids_for_Ménière's_Disease_">Find Related Articles</a> </description></item><item><title>Blocking the Glucocorticoid Receptor with RU-486 Does Not Prevent Glucocorticoid Control of Autoimmune Mouse Hearing Loss.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923812/full_citation/Blocking_the_Glucocorticoid_Receptor_with_RU_486_Does_Not_Prevent_Glucocorticoid_Control_of_Autoimmune_Mouse_Hearing_Loss_</link><description>Trune DR, Kempton JB <br/><span class="title">Blocking the Glucocorticoid Receptor with RU-486 Does Not Prevent Glucocorticoid Control of Autoimmune Mouse Hearing Loss. [JOURNAL ARTICLE]</span><br/><span class="source" title="Audiology &amp; neuro-otology">Audiol Neurootol 2009; 14(6):423-431.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923812/abstract/Blocking_the_Glucocorticoid_Receptor_with_RU_486_Does_Not_Prevent_Glucocorticoid_Control_of_Autoimmune_Mouse_Hearing_Loss_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923812/full_citation/Blocking_the_Glucocorticoid_Receptor_with_RU_486_Does_Not_Prevent_Glucocorticoid_Control_of_Autoimmune_Mouse_Hearing_Loss_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923812/Blocking_the_Glucocorticoid_Receptor_with_RU_486_Does_Not_Prevent_Glucocorticoid_Control_of_Autoimmune_Mouse_Hearing_Loss_">Find Related Articles</a> </description></item><item><title>Pulsed Intravenous Cyclophosphamide and Methylprednisolone Therapy in Refractory Pemphigus.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922532/full_citation/Pulsed_Intravenous_Cyclophosphamide_and_Methylprednisolone_Therapy_in_Refractory_Pemphigus_</link><description>Saha M, Powell AM, Bhogal B, et al. <br/><span class="title">Pulsed Intravenous Cyclophosphamide and Methylprednisolone Therapy in Refractory Pemphigus. [JOURNAL ARTICLE]</span><br/><span class="source" title="The British journal of dermatology">Br J Dermatol 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922532/abstract/Pulsed_Intravenous_Cyclophosphamide_and_Methylprednisolone_Therapy_in_Refractory_Pemphigus_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922532/full_citation/Pulsed_Intravenous_Cyclophosphamide_and_Methylprednisolone_Therapy_in_Refractory_Pemphigus_">Full Citation</a></description></item><item><title>Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922017/full_citation/Hand_bone_loss_measured_by_digital_X_ray_radiogrammetry_is_a_predictor_of_joint_damage_in_early_rheumatoid_arthritis_</link><description>Forslind K, Boonen A, Albertsson K, et al. <br/><span class="title">Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Scandinavian journal of rheumatology">Scand J Rheumatol 2009; 38(6):431-438.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922017/abstract/Hand_bone_loss_measured_by_digital_X_ray_radiogrammetry_is_a_predictor_of_joint_damage_in_early_rheumatoid_arthritis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922017/full_citation/Hand_bone_loss_measured_by_digital_X_ray_radiogrammetry_is_a_predictor_of_joint_damage_in_early_rheumatoid_arthritis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922017/Hand_bone_loss_measured_by_digital_X_ray_radiogrammetry_is_a_predictor_of_joint_damage_in_early_rheumatoid_arthritis_">Find Related Articles</a> </description></item><item><title>Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921987/full_citation/Early_high_dose_immunosuppression_in_Henoch_Schönlein_nephrotic_syndrome_may_improve_outcome_</link><description>Andersen RF, Rubak S, Jespersen B, et al. <br/><span class="title">Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome. [JOURNAL ARTICLE]</span><br/><span class="source" title="Scandinavian journal of urology and nephrology">Scand J Urol Nephrol 2009; 43(5):409-415.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921987/abstract/Early_high_dose_immunosuppression_in_Henoch_Schönlein_nephrotic_syndrome_may_improve_outcome_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921987/full_citation/Early_high_dose_immunosuppression_in_Henoch_Schönlein_nephrotic_syndrome_may_improve_outcome_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19921987/Early_high_dose_immunosuppression_in_Henoch_Schönlein_nephrotic_syndrome_may_improve_outcome_">Find Related Articles</a> </description></item><item><title>Primary cardiac lymphoma: diagnostic tools and treatment challenges.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921311/full_citation/Primary_cardiac_lymphoma:_diagnostic_tools_and_treatment_challenges_</link><description>Bambury R, Gallagher F, Dodd JD, et al. <br/><span class="title">Primary cardiac lymphoma: diagnostic tools and treatment challenges. [JOURNAL ARTICLE]</span><br/><span class="source" title="Irish journal of medical science">Ir J Med Sci 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921311/abstract/Primary_cardiac_lymphoma:_diagnostic_tools_and_treatment_challenges_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921311/full_citation/Primary_cardiac_lymphoma:_diagnostic_tools_and_treatment_challenges_">Full Citation</a></description></item><item><title>Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921083/full_citation/Effect_of_alendronate_on_bone_metabolic_indices_and_bone_mineral_density_in_patients_treated_with_high_dose_glucocorticoid:_a_prospective_study_</link><description>Kaji H, Kuroki Y, Murakawa Y, et al. <br/><span class="title">Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA">Osteoporos Int 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921083/abstract/Effect_of_alendronate_on_bone_metabolic_indices_and_bone_mineral_density_in_patients_treated_with_high_dose_glucocorticoid:_a_prospective_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921083/full_citation/Effect_of_alendronate_on_bone_metabolic_indices_and_bone_mineral_density_in_patients_treated_with_high_dose_glucocorticoid:_a_prospective_study_">Full Citation</a></description></item></channel></rss>